Invention Grant
- Patent Title: Adjuvanted formulations of booster vaccines
-
Application No.: US15163592Application Date: 2016-05-24
-
Publication No.: US09931399B2Publication Date: 2018-04-03
- Inventor: Barbara Baudner , Derek O'Hagan , Manmohan Singh , Simone Bufali
- Applicant: GlaxoSmithKline Biologicals SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/39 ; A61K9/107 ; A61K39/13 ; C12N7/00
Abstract:
The invention improves TdaP vaccines by including a TLR agonist in them. This agonist can provide stronger protection, longer-lasting protection, and/or can reduce the amount of antigen which is required to achieve a particular immune response.
Public/Granted literature
- US20160263216A1 ADJUVANTED FORMULATIONS OF BOOSTER VACCINES Public/Granted day:2016-09-15
Information query
